| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 412,864 | 406,893 | 405,066 | 421,815 | | Cost of Revenue | 101,234 | 134,685 | 143,294 | 128,062 | | | Gross Profit | 311,630 | 272,208 | 261,772 | 293,753 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 36,174 | 8,199 | 9,679 | 5,841 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 85,908 | 83,595 | 85,167 | 104,288 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 166,843 | 180,414 | 166,926 | 183,624 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 74,008 | 33,205 | (27,897) | (19,411) | | Earnings Before Interest And Taxes | 206,528 | 221,017 | 161,840 | (131,772) | | Interest Expense | 7,289 | 7,288 | 8,128 | 8,757 | | Income Before Tax | 199,239 | 213,729 | 153,712 | (140,529) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| (10,344) | | | | Net Income From Continuing Ops | 243,085 | 213,729 | 153,712 | 151,824 | | | Non-recurring Events | | Discontinued Operations | 866 | (8,342) | (283) | (134) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 294,667 | 205,387 | 153,429 | 151,690 | | Preferred Stock And Other Adjustments | (57,358) | (6,215) | 63,573 | 197,067 | | | Net Income Applicable To Common Shares | $237,309 | $199,172 | $217,002 | $348,757 |
|
0.01% Nasdaq 
0.22%
Income Statement
